Indeed, its assumption causes analgesia and respiratory depression in a dose-dependent manner, reaching the maximum peak after six minutes of the injection; analgesia disappears largely after one hour, while respiratory depression tends to last longer than fentanyl. 5 The analgesic activity was determined to be 2.5 times as potent as fentanyl and around 200 times as potent as morphine. 6 This ability to act at very small concentrations, if used illicitly for recreational purposes, determines a high risk of overdose. Unfortunately, some of the attributes that make these drugs so precious are also responsible for their considerable potential for abuse, addiction, and overdose. Reports on the commercialization of non-controlled fentanyl derivatives through the web, such as butyrfentanyl and 4-fluoro-butyrfentanyl, 7 and of acetylfentanyl, 8 are particularly alarming because of the high risk associated with their consumption. 9 Another worrying trend is the use of fentanyl derivatives to adulterate heroin, which began three decades ago 10 and continues to this day. 9 A recent review has reported the presence of ocfentanil (OcF) in several samples sold as heroin in the hidden web. 8 Taken together, these data tell us how these designer opioids, such as OcF, represent a serious concern for public health, since they are both toxic at low dose and often sold as heroin to unsuspecting users. To date, a death involving OcF has been published in Belgium 11 and in Switzerland, 12 both in 2016. To our knowledge, this paper describes the first reported death involving OcF which occurred in Italy (in 2017). An ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) based method was developed and validated for OcF identification and quantitation.
| CASE REPORT
A 39-year-old white man with a history of heroin abuse was found dead in the cellar of his house. A syringe, a lighter, and a resealable plastic zipper bag (minigrip) containing several hundred milligrams of a brown powder were found close to the dead body by the police officers. First, a heroin overdose was suspected. After six years of detoxification and a severe relapse, he had started to attend a drug rehabilitation program and before his death he was being treated with buprenorphine and sedatives, in case of need. During the autopsy, a body examination revealed some injection sites at his elbow grooves, a pulmonary congestion, and an edema (left lung 950 g and right lung 1045 g), while his heart (410 g) and brain (1350 g) did not show any pathological findings. Samples of cardiac and femoral blood, bile, urine, brain, liver, gastric content, kidney, lung, hair, and nasal swab were collected and maintained at −20°C until toxicological analysis. In addition, samples were taken for histological analysis but not submitted to analysis, since they were not requested by the Public Prosecutor. In addition, general unknown screening in blood, urine, and in the brown powder was conducted by gas chromatography mass spectrometry (GC-MS) in order to identify additional drugs or metabolites after acidic and basic extraction and derivatization according to
Maurer et al.. 13 This procedure was also used to identify OcF in the biological samples and in the powder as described in Section 3.2.
Drugs of abuse, fentanyl, and new fentanyl derivatives were also investigated in hair specimens. After decontamination with 3 mL dichloromethane, proximal (0-1.5 cm) and distal (1.5-3 cm) hair sections were reduced in short cuts (2-4 mm) and dried. Hair extraction and analysis by GC-MS was performed in accordance to an internal validated procedure 14, 15 in particular for the determination of fentanyl 
| Instrumental conditions
UHPLC-MS/MS analyses were performed on a 1290 Infinity ultrahigh-performance liquid chromatography system (Agilent Technologies, Palo Alto, CA, USA) coupled to a Q Trap 5500 linear ion trap triple quadrupole mass spectrometer (Sciex, Darmstadt, Germany) and equipped with an electrospray ionization (ESI) source. Chromatographic separation was carried out on a Kinetex HPLC XB-C18 column (100 mm length x 2.1 mm i.d, 2.6 particle size) at 30°C using a linear gradient elution with two solvents: 0.1% formic acid (solvent A) and 0.1% formic acid in acetonitrile (solvent B). Solvent A and B were 90% and 10% at 0.00 minutes, respectively. Solvent B was increased to 25% from 0.00 to 2.00 minutes, then increased to 90% from 2.00 to 3.50 minutes and to 98% from 3.50 to 4.00 minutes, held at 98% from 4.00 to 5.40 minutes, and then decreased back to 10% from 5.40 to 5.50 minutes and held at 10% from 5.50 to 7.50 minutes for re-equilibration. The flow rate was kept constant at 0.5 mL/min during the analysis. The separated analytes were detected with a triple quadrupole mass spectrometer operated in multiple reaction monitoring (MRM) mode via positive ESI using the precursor ion and product ions transition shown in Table 1 . The instrumental conditions were optimized by direct infusion (flow rate 7 μL/min) of OcF solution (100 ng/mL) and were as follows: Entrance potential 10 eV, curtain gas 25 psi, ion spray voltage 5500 eV, ion source temperature 500°C, ion source gas 1 45 psi, and ion source gas 2 40 psi. Data acquisition and processing was performed using Analyst ® 1. 
| Specimens preparation and extraction
Biological specimens as kidney, liver, lung, and brain were homogenized in TRIS (5 mL for 1 g) by addition of the protease from Bacillus licheniformis (9.3 units/mg solid) and ultrasonicated for two hours.
An aliquot of diluted tissue (500 μL) and liquid specimens such as cardiac and femoral blood (500 μL), urine (50 μL), and bile (20 μL) was added by 5 μL IS (remifentanil 1 μg/mL) and 2 mL of acetate buffer solution at pH 4 under vortex-mixed agitation. After centrifugation, the upper layer was extracted following a previous validated procedure. 14 The organic phase was evaporated to dryness with a gentle stream of nitrogen and the residue was dissolved with methanol (100 μL). 1 μL aliquot was then injected into the UHPLC-MS/MS system, and analyzed as described in Section 3.2.2.
| RESULTS
As a first step, GC-MS screening was applied to the brown powder and typical cutting agents of street heroin such as acetaminophen and caffeine were found, in addition to OcF (2.48%). The identification was obtained by means of a good fit of the obtained mass spectra with the SWGDRUG library version 2.3 installed on the Agilent Chemstation (as described in Figure 1 for OcF).
Same analysis was performed on the previously mentioned post- ), in addition to OcF.
As previously described, a hair sample was also analyzed in GC-MS, after splitting in proximal and distal section, with the following results: cocaine (proximal: 2.33 ng/mg; distal:
1.69 ng/mg) and benzoylecgonine (proximal: 0.31 ng/mg; distal:
0.15 ng/mg).
As soon as the OcF reference compound was available, both automated extraction procedure and UHPLC-MS/MS method were developed and validated for OcF identification and quantitation, as described in Section 3.
All calibration curves showed good linearity (r 2 > 0.9994) over the entire investigated range when using linear correlation. The % CV at the low concentration point was found to be 5.3%, whereas LOD and LOQ obtained were 0.03 and 0.10 ng/mL, respectively. An overview of the assessed validation data is shown in Table 2 .
The validated method was then applied to obtain a distribution of OcF in the post-mortem fluids (urine, bile, cardiac, and femoral blood) and tissue specimens (kidney, liver, lung, and brain), following an internal extraction procedure 14 previously set up for hair samples, with some minor modification in the pre-extraction step, as described in Section 3.2.4. Figure 2 reports MRM chromatograms relative to OcF (A) and the certified reference OcF spiked in blank plasma (B). OcF was detected in all post-mortem specimens, at different level, as reported in Table 3 .
FIGURE 1
Mass spectra relative to OcF from A, brown powder and B, reference from SWGDRUG library 
| DISCUSSION AND CONCLUSION
This article reports a case of acute intoxication caused by OcF injection.
To obtain a diagnosis of death, a forensic-based method involving anamnestic, clinical, and circumstantial, anatomo-pathological and toxicological criteria was used. It was known that the deceased person had a substantial anamnestic history of drug addiction when in life, which may direct the diagnosis toward a death correlated with a chemical OcF levels in tissues -and with average fentanyl levels reported in lethal fentanyl-related intoxication. 17 As we can see, in our case the OcF levels were higher than the others, in all the specimens, confirming acute intoxication. This statement is supported in case of lack of tolerance to the synthetic opioids such as fentanyl and new fentanyl derivatives and/or to other opioids, as in this subject. Indeed, the 3 cm-hair analysis revealed the only presence of cocaine and no opioid compounds at all, to confirm regular abuse only for the first one. In particular, no traces of buprenorphine, fentanyl, and other new fentanyl derivatives were detected in the keratin matrix. Nothing can be said about the will of the subject to take OcF; it is not clear if the consumer was aware of the real composition of the powder he gave himself or whether he thought he was taking heroin. Indeed, there are documented cases in which the drug, purchased online as heroin, has showed no trace of it but a composition based on (in order of magni- 
